CAPR Financial Statements

Balance sheet, income statement, cash flow, and dividends for Capricor Therapeutics Inc (CAPR).


$627.48M Market Cap.

As of 03/27/2025 5:00 PM ET (MRY) • Disclaimer

CAPR Market Cap. (MRY)


CAPR Shares Outstanding (MRY)


CAPR Assets (MRY)


Total Assets

$170.48M

Total Liabilities

$25.02M

Total Investments

$140.23M

CAPR Income (MRY)


Revenue

$22.27M

Net Income

-$40.47M

Operating Expense

$64.84M

CAPR Cash Flow (MRY)


CF Operations

-$40.00M

CF Investing

-$116.18M

CF Financing

$152.77M

CAPR Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

CAPR Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$170,481,086 (190.26%)

$58,734,327 (17.25%)

$50,094,910 (21.21%)

$41,330,323 (19.39%)

Assets Current

$163,385,267 (221.27%)

$50,855,472 (18.58%)

$42,888,734 (17.71%)

$36,436,961 (8.20%)

Assets Non-Current

$7,095,819 (-9.94%)

$7,878,855 (9.33%)

$7,206,176 (47.26%)

$4,893,362 (419.62%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$145,462,336 (543.60%)

$22,601,467 (91.76%)

$11,786,094 (-62.43%)

$31,367,966 (11.23%)

Property Plant & Equipment Net

$6,874,119 (-9.68%)

$7,610,683 (9.70%)

$6,938,004 (50.25%)

$4,617,640 (442.71%)

Cash & Equivalents

$11,286,996 (-23.19%)

$14,694,857 (53.02%)

$9,603,242 (-72.47%)

$34,885,274 (6.79%)

Accumulated Other Comprehensive Income

$1,026,955 (335.50%)

$235,813 (124.06%)

$105,244 (0%)

$0 (0%)

Deferred Revenue

$12,000,000 (-50.56%)

$24,270,465 (-11.58%)

$27,448,531 (0%)

$0 (0%)

Total Investments

$140,228,881 (465.60%)

$24,792,846 (-22.08%)

$31,818,020 (0%)

$0 (0%)

Investments Current

$140,228,881 (465.60%)

$24,792,846 (-22.08%)

$31,818,020 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$10,368,489 (-0.03%)

$10,371,993 (1794.15%)

$547,580 (39.78%)

$391,750 (0%)

Trade & Non-Trade Payables

$8,191,377 (31.06%)

$6,250,241 (26.94%)

$4,923,917 (32.51%)

$3,715,759 (36.38%)

Accumulated Retained Earnings (Deficit)

-$199,834,539 (-25.39%)

-$159,367,353 (-16.26%)

-$137,079,811 (-26.85%)

-$108,060,279 (-22.74%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,451,114 (-35.10%)

$2,235,895 (-12.66%)

$2,560,109 (-10.81%)

$2,870,339 (802.17%)

Debt Current

$834,799 (11.44%)

$749,112 (9.83%)

$682,039 (63.31%)

$417,632 (69.29%)

Debt Non-Current

$616,315 (-58.55%)

$1,486,783 (-20.83%)

$1,878,070 (-23.43%)

$2,452,707 (3331.75%)

Total Liabilities

$25,018,750 (-30.76%)

$36,132,860 (-5.68%)

$38,308,816 (284.54%)

$9,962,357 (55.20%)

Liabilities Current

$21,026,176 (-32.76%)

$31,269,818 (32.57%)

$23,586,555 (470.63%)

$4,133,391 (39.11%)

Liabilities Non-Current

$3,992,574 (-17.90%)

$4,863,042 (-66.97%)

$14,722,261 (152.57%)

$5,828,966 (69.07%)

CAPR Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$22,270,465 (-11.55%)

$25,178,066 (886.81%)

$2,551,469 (941.85%)

$244,898 (-21.06%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$14,866,722 (16.07%)

$12,807,886 (22.78%)

$10,431,903 (37.04%)

$7,612,295 (37.33%)

Research & Development Expense

$49,968,585 (37.10%)

$36,448,039 (67.06%)

$21,816,949 (60.76%)

$13,571,045 (60.47%)

Operating Expenses

$64,835,307 (31.63%)

$49,255,925 (52.74%)

$32,248,852 (52.24%)

$21,183,340 (51.31%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$40,467,186 (-81.57%)

-$22,287,542 (23.20%)

-$29,019,532 (-44.93%)

-$20,022,520 (-46.61%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$40,467,186 (-81.57%)

-$22,287,542 (23.20%)

-$29,019,532 (-44.93%)

-$20,022,520 (-46.61%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$40,467,186 (-81.57%)

-$22,287,542 (23.20%)

-$29,019,532 (-44.93%)

-$20,022,520 (-46.61%)

Weighted Average Shares

$35,218,628 (31.52%)

$26,778,360 (9.06%)

$24,552,688 (6.34%)

$23,089,323 (48.28%)

Weighted Average Shares Diluted

$35,218,628 (31.52%)

$26,778,360 (9.06%)

$24,552,688 (6.34%)

$23,089,323 (48.28%)

Earning Before Interest & Taxes (EBIT)

-$40,467,186 (-81.57%)

-$22,287,542 (23.20%)

-$29,019,532 (-44.93%)

-$20,022,520 (-46.61%)

Gross Profit

$22,270,465 (-11.55%)

$25,178,066 (886.81%)

$2,551,469 (941.85%)

$244,898 (-21.06%)

Operating Income

-$42,564,842 (-76.78%)

-$24,077,859 (18.92%)

-$29,697,383 (-41.83%)

-$20,938,442 (-52.95%)

CAPR Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$116,183,868 (-2374.45%)

$5,108,210 (114.56%)

-$35,072,507 (-2831.78%)

-$1,196,286 (-121.99%)

Net Cash Flow from Financing

$152,771,749 (497.23%)

$25,579,950 (424.84%)

$4,873,838 (-75.90%)

$20,225,010 (-39.41%)

Net Cash Flow from Operations

-$39,995,742 (-56.25%)

-$25,596,545 (-620.61%)

$4,916,637 (129.25%)

-$16,809,324 (-67.18%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,407,861 (-166.93%)

$5,091,615 (120.14%)

-$25,282,032 (-1239.14%)

$2,219,400 (-92.28%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$114,644,893 (-1702.14%)

$7,155,743 (122.56%)

-$31,712,776 (0%)

$0 (0%)

Capital Expenditure

-$1,538,975 (24.84%)

-$2,047,533 (39.06%)

-$3,359,731 (-180.85%)

-$1,196,286 (-118.46%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$152,771,749 (497.23%)

$25,579,950 (424.84%)

$4,873,838 (-75.90%)

$20,225,010 (-38.83%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$9,765,164 (32.10%)

$7,392,396 (65.80%)

$4,458,578 (50.34%)

$2,965,692 (51.88%)

Depreciation Amortization & Accretion

$1,425,214 (33.34%)

$1,068,882 (100.49%)

$533,131 (116.99%)

$245,697 (70.75%)

CAPR Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-181.70% (-105.31%)

-88.50% (92.22%)

-1137.40% (86.09%)

-8175.90% (-85.74%)

EBITDA Margin

-175.30% (-107.95%)

-84.30% (92.45%)

-1116.50% (86.17%)

-8075.50% (-85.40%)

Return on Average Equity (ROAE)

-66.40% (77.84%)

-299.70% (-82.19%)

-164.50% (-183.13%)

-58.10% (-6.22%)

Return on Average Assets (ROAA)

-46.10% (-1.32%)

-45.50% (10.96%)

-51.10% (-7.13%)

-47.70% (-6.71%)

Return on Sales (ROS)

-181.70% (-105.31%)

-88.50% (92.22%)

-1137.40% (86.09%)

-8175.90% (-85.74%)

Return on Invested Capital (ROIC)

-94.50% (74.11%)

-365.00% (-102.78%)

-180.00% (96.94%)

-5873.70% (-397.09%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-12 (-103.67%)

-5.89 (-80.13%)

-3.27 (2.88%)

-3.37 (13.60%)

Price to Sales Ratio (P/S)

21.82 (319.59%)

5.2 (-86.00%)

37.15 (-86.55%)

276.24 (60.47%)

Price to Book Ratio (P/B)

4.31 (-35.24%)

6.66 (-19.41%)

8.27 (266.45%)

2.26 (-9.29%)

Debt to Equity Ratio (D/E)

0.17 (-89.24%)

1.6 (-50.80%)

3.25 (922.01%)

0.32 (39.47%)

Earnings Per Share (EPS)

-1.15 (-38.55%)

-0.83 (29.66%)

-1.18 (-35.63%)

-0.87 (1.14%)

Sales Per Share (SPS)

0.63 (-32.77%)

0.94 (803.85%)

0.1 (845.45%)

0.01 (-45.00%)

Free Cash Flow Per Share (FCFPS)

-1.18 (-14.24%)

-1.03 (-1738.10%)

0.06 (108.08%)

-0.78 (-14.54%)

Book Value Per Share (BVPS)

4.13 (389.34%)

0.84 (75.83%)

0.48 (-64.68%)

1.36 (-24.96%)

Tangible Assets Book Value Per Share (TABVPS)

4.84 (120.75%)

2.19 (7.50%)

2.04 (13.97%)

1.79 (-19.48%)

Enterprise Value Over EBIT (EV/EBIT)

-14 (-133.33%)

-6 (-100.00%)

-3 (-200.00%)

-1 (66.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

-14.36 (-111.63%)

-6.79 (-110.58%)

-3.22 (-113.02%)

-1.51 (41.83%)

Asset Turnover

0.25 (-50.58%)

0.51 (1042.22%)

0.04 (650.00%)

0.01 (-40.00%)

Current Ratio

7.77 (377.92%)

1.63 (-10.56%)

1.82 (-79.38%)

8.81 (-22.23%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$41,534,717 (-50.25%)

-$27,644,078 (-1875.58%)

$1,556,906 (108.65%)

-$18,005,610 (-69.83%)

Enterprise Value (EV)

$560,755,851 (289.40%)

$144,005,685 (56.87%)

$91,798,569 (206.84%)

$29,917,866 (-14.89%)

Earnings Before Tax (EBT)

-$40,467,186 (-81.57%)

-$22,287,542 (23.20%)

-$29,019,532 (-44.93%)

-$20,022,520 (-46.61%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$39,041,972 (-84.00%)

-$21,218,660 (25.51%)

-$28,486,401 (-44.04%)

-$19,776,823 (-46.35%)

Invested Capital

$139,619,028 (830.45%)

$15,005,547 (-22.91%)

$19,465,222 (275.63%)

$5,181,997 (837.79%)

Working Capital

$142,359,091 (626.85%)

$19,585,654 (1.47%)

$19,302,179 (-40.25%)

$32,303,570 (5.20%)

Tangible Asset Value

$170,481,086 (190.26%)

$58,734,327 (17.25%)

$50,094,910 (21.21%)

$41,330,323 (19.39%)

Market Capitalization

$627,484,730 (316.72%)

$150,577,129 (54.55%)

$97,431,812 (37.70%)

$70,757,024 (0.89%)

Average Equity

$60,916,135 (719.01%)

$7,437,806 (-57.85%)

$17,646,062 (-48.80%)

$34,466,213 (38.07%)

Average Assets

$87,788,648 (79.38%)

$48,940,316 (-13.77%)

$56,752,627 (35.20%)

$41,976,324 (37.37%)

Invested Capital Average

$42,826,103 (601.35%)

$6,106,220 (-62.13%)

$16,124,367 (4630.19%)

$340,882 (149.35%)

Shares

45,469,908 (47.66%)

30,792,869 (21.99%)

25,241,402 (4.52%)

24,149,155 (18.10%)